# NGN BioMed Opportunity Annex Fund, L.P. — Form D

NGN BioMed Opportunity Annex Fund, L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2013-01-31. The offering totals $22.5M, of which $19.2M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2013-01-31
- Form: D
- Accession: 0001565713-13-000001
- Industry: Pooled Investment Fund
- Exemptions: 06, 3C, 3C.1
- Total offering: $22.5M
- Amount sold: $19.2M
- Remaining: $3.3M
- Investors: 20
- Date of first sale: 2013-01-18
- Security types: fund interests
- SEC file number: 021-191133

## Issuer

- Name: NGN BioMed Opportunity Annex Fund, L.P.
- CIK: 0001565713
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 369 LEXINGTON AVENUE, NEW YORK, NY, 10017
- Phone: 212-972-0077

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| General Partner NGN BioMed I Annex GP, L.P. | Promoter | New York, NY |
| GP of General Partner NGN Capital LLC | Promoter | New York, NY |

## More

- [CIK 1565713 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1565713&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001565713-13-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.